FindTrial
Sign In

Impact of different antiretroviral therapy (ART) regimens on lipid metabolism in people living with HIV

Impact of different antiretroviral therapy (ART) regimens on lipid metabolism in people living with HIV

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061677
Enrollment
Unknown
Registered
2022-06-30
Start date
2022-06-30
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS

Interventions

group A:EVG/c/TAF/FTC
group B:B/FTC/TAF
group C:DTG/3TC
group D:DTG/3TC/TDF
group E:DTG/FTC/TDF
group F:TDF/3TC/EFV

Sponsors

The First Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. HIV-infected persons aged > 18 years; 2. People who are using ART antiviral therapy or are about to start the ART program for antiviral therapy; 3. No genotypic evidence of viral resistance; 4. Voluntarily sign the patient's informed consent, and can ensure regular follow-up and specimen collection.

Exclusion criteria

Exclusion criteria: 1. Women who are breastfeeding or planning to become pregnant or breastfeeding; 2. Creatinine clearance 5 times ULN, or ALT > 3 times ULN and bilirubin > 1.5 times ULN); 4. Combined with opportunistic infections or tumors.

Design outcomes

Primary

MeasureTime frame
lipidomics;—

Countries

China

Contacts

Public ContactBiao Zhu

The First Affiliated Hospital, College of Medicine, Zhejiang University

zhubiao1207@zju.edu.cn+86 13906535457

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026